Anthony Mwololo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anthony Mwololo has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Emily Rogena
Department of Human Pathology, School of Medicine, University of Nairobi, Nairobi, Kenya
1 shared publication - Joshua Nyagol
Department of Human Pathology, University of Nairobi, Nairobi 00202, Kenya
1 shared publication - Lorenzo Leoncini
Department of Medical Biotechnology University of Siena Siena Italy
1 shared publication - Lorenzo Pacenti
Department of Anatomical Pathology and Human Oncology, University of Siena, Siena, Italy
1 shared publication - Mary Kimani
Department of Human Pathology, University of Nairobi, Nairobi, Kenya
1 shared publication - Mwanda Walter Otieno
Department of Human Pathology, University of Nairobi, Nairobi, Kenya
1 shared publication
Latest Publications
- Open Access
- 26 February 2014
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 9 (1) , 7
Correlation of EGFR, pEGFR and p16INK4 expressions and high risk HPV infection in HIV/AIDS-related squamous cell carcinoma of conjunctiva
Squamous cell carcinoma of conjunctiva has increased tenfold in the era of HIV/AIDS. The disease pattern has also changed in Africa, affecting young persons, with peak age-specific incidence of 30-39 years, similar to that of Kaposi sarcoma, a well known HIV/AIDS defining neoplasm. In addition, the disease has assumed more aggressive clinical course. The contributing role of exposure to high risk HPV in the development of SCCC is still emerging.
- 26 February 2014
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 9 (1) , 7
Open AccessCorrelation of EGFR, pEGFR and p16INK4 expressions and high risk HPV infection in HIV/AIDS-related squamous cell carcinoma of conjunctiva
Squamous cell carcinoma of conjunctiva has increased tenfold in the era of HIV/AIDS. The disease pattern has also changed in Africa, affecting young persons, with peak age-specific incidence of 30-39 years, similar to that of Kaposi sarcoma, a well known HIV/AIDS defining neoplasm. In addition, the disease has assumed more aggressive clinical course. The contributing role of exposure to high risk HPV in the development of SCCC is still emerging.